News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) Labs Sued By Five Men Claiming Androgel Injuries


2/7/2014 7:28:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Abbott Laboratories (ABT) and AbbVie Inc., the company it spun off last year, hid the dangers of using the testosterone replacement drug AndroGel, five men claimed in lawsuits. Their complaints, filed in the federal court in Chicago yesterday, came four days after the U.S. Food and Drug Administration said it will re-examine the safety of testosterone replacement drugs after two studies showed a higher risk of heart attacks and strokes in men who use them. The men range in age from 50 to 63, according to their complaints.

Help employers find you! Check out all the jobs and post your resume.

Read at Bloomberg
Read at News Release
Read at News Release
Read at News Release

comments powered by Disqus
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES